Literature DB >> 22814978

Successful salvage using combined radiation and ABMT for patients with recurrent CNS NGGCT following failed initial transplant.

Kyle Malone1, Jennifer Croke, Colin Malone, Shawn Malone.   

Abstract

Intracranial germ cell tumours (GCTs) are a rare and diverse group of tumours. Histology determines the type of treatment, natural history and prognosis. Germinoma GCTs account for the majority and are very radiosensitive. Conversely, non-germinoma GCTs (NGGCTs) are heterogeneous, relatively radioresistant and have a high risk of relapse despite multimodality therapy. Treatment of recurrence in these patients remains a therapeutic challenge. In this report we review the current literature for treatment of recurrent NGGCTs and present a case of recurrent NGGCT who relapsed despite autologous stem cell transplant (ASCT). The patient was successfully cured using multimodality therapy, consisting of repeat ASCT, intensity modulated radiation therapy and stereotactic radiosurgery.

Entities:  

Mesh:

Year:  2012        PMID: 22814978      PMCID: PMC4543289          DOI: 10.1136/bcr-2012-006298

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  18 in total

1.  Treatment of intracranial nongerminomatous germ-cell tumor by high-dose chemotherapy and autologous stem-cell rescue.

Authors:  T Tada; T Takizawa; F Nakazato; S Kobayashi; K Koike; M Oguchi; E Ishii; Y Amano
Journal:  J Neurooncol       Date:  1999-08       Impact factor: 4.130

2.  Combined chemotherapy and radiation therapy for CNS germ cell tumors--the Japanese experience.

Authors:  M Matsutani
Journal:  J Neurooncol       Date:  2001-09       Impact factor: 4.130

3.  High-dose carboplatin, etoposide, and cyclophosphamide for patients with refractory germ cell tumors: treatment results and prognostic factors for survival and toxicity.

Authors:  R J Motzer; M Mazumdar; G J Bosl; D F Bajorin; A Amsterdam; V Vlamis
Journal:  J Clin Oncol       Date:  1996-04       Impact factor: 44.544

4.  Thiotepa-based high-dose chemotherapy with autologous stem-cell rescue in patients with recurrent or progressive CNS germ cell tumors.

Authors:  Shakeel Modak; Sharon Gardner; Ira J Dunkel; Casilda Balmaceda; Marc K Rosenblum; Douglas C Miller; Steven Halpern; Jonathan L Finlay
Journal:  J Clin Oncol       Date:  2004-05-15       Impact factor: 44.544

5.  Carboplatin and recurrent childhood brain tumors.

Authors:  J C Allen; R Walker; E Luks; M Jennings; S Barfoot; C Tan
Journal:  J Clin Oncol       Date:  1987-03       Impact factor: 44.544

6.  Primary chemotherapy for intracranial nongerminomatous germ cell tumors: results of the second international CNS germ cell study group protocol.

Authors:  Stewart J Kellie; Hayden Boyce; Ira J Dunkel; Blanca Diez; Marc Rosenblum; Lynette Brualdi; Jonathan L Finlay
Journal:  J Clin Oncol       Date:  2004-03-01       Impact factor: 44.544

7.  Pineal and CNS germ cell tumors: Royal Marsden Hospital experience 1962-1987.

Authors:  D P Dearnaley; R P A'Hern; S Whittaker; H J Bloom
Journal:  Int J Radiat Oncol Biol Phys       Date:  1990-04       Impact factor: 7.038

Review 8.  Application of stem cell transplant for brain tumors.

Authors:  Sharon L Gardner
Journal:  Pediatr Transplant       Date:  2004-06

Review 9.  Intracranial germ-cell tumors: natural history and pathogenesis.

Authors:  M T Jennings; R Gelman; F Hochberg
Journal:  J Neurosurg       Date:  1985-08       Impact factor: 5.115

10.  High-dose carboplatin and etoposide with autologous bone marrow transplantation in refractory germ cell cancer: an Eastern Cooperative Oncology Group protocol.

Authors:  C R Nichols; J Andersen; H M Lazarus; H Fisher; J Greer; E A Stadtmauer; P J Loehrer; D L Trump
Journal:  J Clin Oncol       Date:  1992-04       Impact factor: 44.544

View more
  1 in total

Review 1.  Re-irradiation of Recurrent Pineal Germ Cell Tumors with Radiosurgery: Report of Two Cases and Review of Literature.

Authors:  Kenneth Wong; Anthony B Opimo; Arthur J Olch; Sean All; Jonathan F Waxer; Desirae Clark; Justine Cheng; Alisha Chlebik; Anat Erdreich-Epstein; Mark D Krieger; Benita Tamrazi; Girish Dhall; Jonathan L Finlay; Eric L Chang
Journal:  Cureus       Date:  2016-04-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.